Stoke Therapeutics, Inc. (STOK)
33.73
-0.30
(-0.88%)
USD |
NASDAQ |
Apr 27, 16:00
33.73
0.00 (0.00%)
After-Hours: 17:33
Stoke Therapeutics Profit Margin (Quarterly) : -4.13K% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biogen, Inc. | -2.24% |
| Krystal Biotech, Inc. | 47.99% |
| Scholar Rock Holding Corp. | -- |
| Vertex Pharmaceuticals, Inc. | 36.91% |
| Zymeworks, Inc. | -1.64K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -2.19% |
| Return on Assets | -1.87% |
| Return on Invested Capital | -2.16% |
| Gross Profit Margin (Quarterly) | 24.75% |
| Operating Margin (Quarterly) | -4.38K% |
| Return on Net Operating Assets | -32.95% |